These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 27798391)
21. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Morrissey LK; Shea JO; Kalish LA; Weiner DL; Branowicki P; Heeney MM Pediatr Blood Cancer; 2009 Mar; 52(3):369-72. PubMed ID: 19023890 [TBL] [Abstract][Full Text] [Related]
22. Variation in hospital admission of sickle cell patients from the emergency department using the Pediatric Health Information System. Jacob SA; Mueller EL; Cochrane AR; Carroll AE; Bennett WE Pediatr Blood Cancer; 2020 Jun; 67(6):e28067. PubMed ID: 31724788 [TBL] [Abstract][Full Text] [Related]
23. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC; Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249 [TBL] [Abstract][Full Text] [Related]
24. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease. Mathias MD; McCavit TL Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245 [TBL] [Abstract][Full Text] [Related]
25. Sickle cell disease patients' perceptions of emergency department pain management. Porter J; Feinglass J; Artz N; Hafner J; Tanabe P J Natl Med Assoc; 2012; 104(9-10):449-54. PubMed ID: 23342819 [TBL] [Abstract][Full Text] [Related]
26. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit. Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541 [TBL] [Abstract][Full Text] [Related]
27. Opioid prescription practices at discharge and 30-day returns in children with sickle cell disease and pain. Okorji LM; Muntz DS; Liem RI Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27800652 [TBL] [Abstract][Full Text] [Related]
28. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care. Allen Liles E; Kirsch J; Gilchrist M; Adem M Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786 [TBL] [Abstract][Full Text] [Related]
29. Experiences of Pediatric Patients With Sickle Cell Disease in Rural Emergency Departments. Alston KJ; Valrie CR; Walcott C; Warner TD; Fuh B J Pediatr Hematol Oncol; 2015 Apr; 37(3):195-9. PubMed ID: 25389918 [TBL] [Abstract][Full Text] [Related]
30. Emergency department utilization for sickle cell disease in St. Vincent and the Grenadines. Williams SA; Henson S; Trimmingham S; Newman J; Kanter J Pan Afr Med J; 2021; 38():100. PubMed ID: 33889266 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis. Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312 [TBL] [Abstract][Full Text] [Related]
32. Improving Emergency Department-Based Care of Sickle Cell Pain. Glassberg JA Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):412-417. PubMed ID: 29222286 [TBL] [Abstract][Full Text] [Related]
33. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain. Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR; Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794 [TBL] [Abstract][Full Text] [Related]
34. Outcome of short-term emergency department observation care of children with sickle cell disease and vaso-occlusive crises: initial experience from south-western Nigeria. Adegoke SA; Oladimeji OI; Ologun BG; Aladekomo TA; Oyelami OA Trans R Soc Trop Med Hyg; 2020 May; 114(5):365-371. PubMed ID: 32181486 [TBL] [Abstract][Full Text] [Related]
35. A Standardized Emergency Department Order Set Decreases Admission Rates and In-Patient Length of Stay for Adults Patients with Sickle Cell Disease. Wachnik AA; Welch-Coltrane JL; Adams MCB; Blumstein HA; Pariyadath M; Robinson SG; Saha A; Summers EC; Hurley RW Pain Med; 2022 Dec; 23(12):2050-2060. PubMed ID: 35708651 [TBL] [Abstract][Full Text] [Related]
36. What is the best pharmacologic treatment for sickle cell disease pain crises? Baker M; Hafner JW Ann Emerg Med; 2012 Jun; 59(6):515-6. PubMed ID: 22221839 [No Abstract] [Full Text] [Related]
37. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease. Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158 [TBL] [Abstract][Full Text] [Related]
38. Emergency Department Provider Survey Regarding Acute Sickle Cell Pain Management. Martin OY; Thompson SM; Carroll AE; Jacob SA J Pediatr Hematol Oncol; 2020 Aug; 42(6):375-380. PubMed ID: 32569034 [TBL] [Abstract][Full Text] [Related]
39. Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis. Lanzkron S; Carroll CP; Hill P; David M; Paul N; Haywood C Am J Hematol; 2015 May; 90(5):376-80. PubMed ID: 25639822 [TBL] [Abstract][Full Text] [Related]